PROTHENA CORPORATION PUBLIC LIMITED COMPANY Increase (Decrease) in Accounts Payable and Accrued Liabilities
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$14.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$11.83M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$2.22M, a 344.18% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$6.25M, a 413.86% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$1.63M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$15.78M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$18.30M, a 180.06% decline from fiscal 2023.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $22.86M, a 92.63% increase from fiscal 2022.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $11.87M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$14.05M 10-Q · filed 2026-08-06 | -$20.30M derived: sum of 3 quarters · filed 2026-08-06 | -$21.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.22M 10-Q · filed 2026-05-07 | -$8.47M derived: sum of 2 quarters · filed 2026-05-07 | -$10.10M derived: sum of 3 quarters · filed 2026-05-07 | -$18.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$7.88M derived: sum of 2 quarters · filed 2026-02-27 | -$16.69M derived: sum of 3 quarters · filed 2026-08-06 | -$15.78M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$10.44M derived: sum of 2 quarters · filed 2026-08-06 | -$9.53M 10-Q · filed 2025-11-06 | -$7.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.89M 10-Q · filed 2026-08-06 | -$5.90M derived: sum of 3 quarters · filed 2026-08-06 | -$7.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $910.00K 10-Q · filed 2026-05-07 | $2.90M derived: sum of 2 quarters · filed 2026-05-07 | $1.71M derived: sum of 3 quarters · filed 2026-05-07 | -$2.93M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $804.00K derived: sum of 2 quarters · filed 2026-02-27 | -$3.84M derived: sum of 3 quarters · filed 2026-02-27 | -$18.30M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.83M derived: sum of 2 quarters · filed 2025-11-06 | -$20.29M 10-Q · filed 2025-11-06 | -$15.93M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$4.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$19.10M 10-Q · filed 2025-08-04 | -$14.74M derived: sum of 3 quarters · filed 2026-02-27 | -$6.62M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$14.46M 10-Q · filed 2025-05-08 | -$10.10M derived: sum of 2 quarters · filed 2026-02-27 | -$1.98M derived: sum of 3 quarters · filed 2026-02-27 | $6.67M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.48M derived: sum of 2 quarters · filed 2026-02-27 | $21.13M derived: sum of 3 quarters · filed 2026-02-27 | $22.86M 10-K · filed 2026-02-27 |
| 2023-09-30 | $8.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $16.77M derived: sum of 2 quarters · filed 2024-11-12 | $18.50M 10-Q · filed 2024-11-12 | $18.54M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $8.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $10.38M 10-Q · filed 2024-08-08 | $10.41M derived: sum of 3 quarters · filed 2025-02-27 | $18.13M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.73M 10-Q · filed 2024-05-08 | $1.77M derived: sum of 2 quarters · filed 2025-02-27 | $9.48M derived: sum of 3 quarters · filed 2025-02-27 | $11.85M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.75M derived: sum of 2 quarters · filed 2025-02-27 | $10.12M derived: sum of 3 quarters · filed 2025-02-27 | $11.87M 10-K · filed 2025-02-27 |
| 2022-09-30 | $7.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $10.08M derived: sum of 2 quarters · filed 2023-11-02 | $11.83M 10-Q · filed 2023-11-02 | $15.54M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.11M 10-Q · filed 2023-08-03 | $7.82M derived: sum of 3 quarters · filed 2024-02-22 | $1.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $1.75M 10-Q · filed 2023-05-04 | $5.46M derived: sum of 2 quarters · filed 2024-02-22 | -$534.00K derived: sum of 3 quarters · filed 2024-02-22 | $4.10M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$2.28M derived: sum of 2 quarters · filed 2024-02-22 | $2.36M derived: sum of 3 quarters · filed 2024-02-22 | -$492.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | -$5.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.35M derived: sum of 2 quarters · filed 2022-11-03 | -$4.20M 10-Q · filed 2022-11-03 | -$143.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $4.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.79M 10-Q · filed 2022-08-08 | $5.85M derived: sum of 3 quarters · filed 2023-02-28 | $8.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$2.85M 10-Q · filed 2022-05-05 | $1.21M derived: sum of 2 quarters · filed 2023-02-28 | $4.29M derived: sum of 3 quarters · filed 2023-02-28 | $5.63M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.14M derived: sum of 2 quarters · filed 2023-02-28 | $8.48M derived: sum of 3 quarters · filed 2023-02-28 | $7.73M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.42M derived: sum of 2 quarters · filed 2021-11-04 | $3.67M 10-Q · filed 2021-11-04 | -$10.40M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $589.00K 10-Q · filed 2021-08-05 | -$13.48M derived: sum of 3 quarters · filed 2022-02-25 | -$9.90M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$748.00K 10-Q · filed 2021-05-11 | -$14.82M derived: sum of 2 quarters · filed 2022-02-25 | -$11.24M derived: sum of 3 quarters · filed 2022-02-25 | $1.77M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$14.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$10.49M derived: sum of 2 quarters · filed 2022-02-25 | $2.52M derived: sum of 3 quarters · filed 2022-02-25 | -$78.00K 10-K · filed 2022-02-25 |
| 2019-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $16.59M derived: sum of 2 quarters · filed 2020-11-04 | $13.99M 10-Q · filed 2020-11-04 | $11.71M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $13.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $10.41M 10-Q · filed 2020-08-06 | $8.13M derived: sum of 3 quarters · filed 2021-02-26 | -$2.99M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$2.60M 10-Q · filed 2020-05-06 | -$4.88M derived: sum of 2 quarters · filed 2021-02-26 | -$16.00M derived: sum of 3 quarters · filed 2021-02-26 | -$25.49M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$13.41M derived: sum of 2 quarters · filed 2021-02-26 | -$22.89M derived: sum of 3 quarters · filed 2021-02-26 | -$25.63M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$11.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$20.61M derived: sum of 2 quarters · filed 2019-11-05 | -$23.34M 10-Q · filed 2019-11-05 | -$26.42M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$9.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$12.22M 10-Q · filed 2019-08-06 | -$15.30M derived: sum of 3 quarters · filed 2020-03-03 | -$16.39M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | -$2.73M 10-Q · filed 2019-05-07 | -$5.81M derived: sum of 2 quarters · filed 2020-03-03 | -$6.90M derived: sum of 3 quarters · filed 2020-03-03 | $243.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$4.16M derived: sum of 2 quarters · filed 2020-03-03 | $2.98M derived: sum of 3 quarters · filed 2020-03-03 | $147.00K 10-K · filed 2020-03-03 |
| 2017-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $6.05M derived: sum of 2 quarters · filed 2018-11-06 | $3.22M 10-Q · filed 2018-11-06 | $7.41M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $7.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $4.31M 10-Q · filed 2018-08-07 | $8.50M derived: sum of 3 quarters · filed 2019-03-15 | $10.15M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$2.83M 10-Q · filed 2018-05-09 | $1.36M derived: sum of 2 quarters · filed 2019-03-15 | $3.01M derived: sum of 3 quarters · filed 2019-03-15 | $11.75M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $5.84M derived: sum of 2 quarters · filed 2019-03-15 | $14.58M derived: sum of 3 quarters · filed 2019-03-15 | $15.19M 10-K · filed 2019-03-15 |
| 2016-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $10.39M derived: sum of 2 quarters · filed 2017-11-07 | $11.00M 10-Q · filed 2017-11-07 | $14.66M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $8.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $9.35M 10-Q · filed 2017-08-09 | $13.01M derived: sum of 3 quarters · filed 2018-02-26 | $18.60M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $609.00K 10-Q · filed 2017-05-09 | $4.27M derived: sum of 2 quarters · filed 2018-02-26 | $9.86M derived: sum of 3 quarters · filed 2018-02-26 | $13.99M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $9.25M derived: sum of 2 quarters · filed 2018-02-26 | $13.38M derived: sum of 3 quarters · filed 2018-02-26 | $11.16M 10-K · filed 2018-02-26 |
| 2015-09-30 | $5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $9.72M derived: sum of 2 quarters · filed 2016-11-02 | $7.50M 10-Q · filed 2016-11-02 | $9.74M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $1.91M 10-Q · filed 2016-08-02 | $4.14M derived: sum of 3 quarters · filed 2017-02-27 | $3.16M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | -$2.22M 10-Q · filed 2016-05-04 | $15.00K derived: sum of 2 quarters · filed 2017-02-27 | -$967.00K derived: sum of 3 quarters · filed 2017-02-27 | $1.46M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.25M derived: sum of 2 quarters · filed 2017-02-27 | $3.69M derived: sum of 3 quarters · filed 2017-02-27 | $5.43M 10-K · filed 2017-02-27 |
| 2014-09-30 | -$982.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $1.45M derived: sum of 2 quarters · filed 2015-11-02 | $3.19M 10-Q · filed 2015-11-02 | $3.69M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $4.18M 10-Q · filed 2015-08-05 | $4.68M derived: sum of 3 quarters · filed 2016-02-25 | $2.94M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $1.75M 10-Q · filed 2015-05-06 | $2.25M derived: sum of 2 quarters · filed 2016-02-25 | $509.00K derived: sum of 3 quarters · filed 2016-02-25 | $4.30M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$1.24M derived: sum of 2 quarters · filed 2016-02-25 | $2.55M derived: sum of 3 quarters · filed 2016-02-25 | $6.23M 10-K · filed 2016-02-25 |
| 2013-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $2.05M derived: sum of 2 quarters · filed 2014-11-04 | $5.73M 10-Q · filed 2014-11-04 | $2.46M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $7.47M 10-Q · filed 2014-08-05 | $4.20M derived: sum of 3 quarters · filed 2015-03-13 | $4.85M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $3.68M 10-Q · filed 2014-05-05 | $406.00K derived: sum of 2 quarters · filed 2015-03-13 | $1.06M derived: sum of 3 quarters · filed 2015-03-13 | -$1.39M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$2.62M derived: sum of 2 quarters · filed 2015-03-13 | -$5.07M derived: sum of 3 quarters · filed 2015-03-13 | -$6.54M 10-K · filed 2015-03-13 |
| 2012-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$1.80M derived: sum of 2 quarters · filed 2013-11-12 | -$3.26M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$3.91M 10-Q · filed 2013-08-13 | ||
| 2012-03-31 | -$1.46M 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | $6.76M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |